NCT06376214 2024-04-19Daratumumab for Patients With Light Chain AmyloidosisNanjing University School of MedicinePhase NA Recruiting100 enrolled
NCT03959358 2023-07-24A Study to Desensitize Allergic Reactions to Treatments for Blood DisordersUniversity Health Network, TorontoPhase 2 Completed10 enrolled
NCT01807286 2016-05-13Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL AmyloidosisM.D. Anderson Cancer CenterPhase 1 Terminated3 enrolled